
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
3
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
3 competitors in Hypertension
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Giapreza
Giapreza is indicated for the treatment of refractory hypotension in adults with septic or other distributive shock who remain hypotensive despite adequate volume restitution and application of catecholamines and other available vasopressor therapies.
View on EMAEdarbi
Edarbi is indicated for the treatment of essential hypertension in adults.
View on EMAIpreziv
Ipreziv is indicated for the treatment of essential hypertension in adults.
View on EMA